Fair Value Calculator Fair Value Calculator
EN DE

BMAL (BMAL) Fair Value & Analysis

IN · Market cap ₹135M

B BMAL BMAL · BSE
Price₹7.30
Fair Value₹3.48
Upside-52.3%
Quality47/100
Watch BMAL for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹3.14 – ₹3.75

Fair value as of: Jul 5, 2026

From 22 valuation models · updated today

Price vs Fair Value (12 months)

₹13.15 ₹7.08 Fair Value ₹3.48 Jul 2025 Jul 2026

12‑month range ₹7.08 – ₹13.15 · fair‑value band ₹3.14 – ₹3.75 · the ₹7.30 price screens above the ₹3.48 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

BMAL (BMAL) currently trades at ₹7.30, while our model-based Fair Value estimate is ₹3.48 — implying the stock looks roughly 52.3% overvalued today. We read business quality at 47/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, BMAL generated revenue of ₹274M at a net margin of 1.0%. Revenue declined 8.4% year over year. It earns a return on equity of 1.5%. Net debt stands at ₹110M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹3.14 (bear case) to ₹3.75 (bull case); at ₹7.30, the current price sits above that range. The share trades about 44% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹274M
Revenue growth (YoY) -8.4%
Net margin 1.0%
Return on equity 1.5%
Free cash flow ₹10.4M FY2026
P/E ratio 48.7
More key figures
Operating margin 3.3%
EPS (TTM) ₹0.1500
EPS growth (YoY) +178%
Net debt ₹110M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

BMAL reported revenue of ₹274M in FY2026 versus ₹1.4M in FY2022, a compound +274.2%/yr. Reported net income was ₹2.7M in FY2026.

Revenue +274.2%/yr
FY22 ₹1.4M
FY23 ₹0
FY24 ₹285M
FY25 ₹258M
FY26 ₹274M
Net income
FY22 −₹12.7M
FY23 −₹11.3M
FY24 ₹2.9M
FY25 ₹3.6M
FY26 ₹2.7M

Is BMAL fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "BMAL Fair Value". https://www.fairvalue-calculator.com/stock/BMAL

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is BMAL (BMAL) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹3.48 versus a price of ₹7.30 — about −52% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BMAL?
Our model-based fair value for BMAL is ₹3.48 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹7.30.
What is the quality score of BMAL?
BMAL has a Quality Score of 47/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of BMAL (BMAL)?
BMAL reported trailing-twelve-month revenue of about ₹274M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of BMAL?
The net profit margin of BMAL is about 1.0%, meaning it keeps roughly 1.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.